Corvus Pharmaceuticals Inc (CRVS)
2.16
+0.05
(+2.37%)
USD |
NASDAQ |
May 31, 16:00
2.15
-0.01
(-0.46%)
After-Hours: 20:00
Corvus Pharmaceuticals Market Cap: 135.11M for May 31, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 31, 2024 | 135.11M |
| May 30, 2024 | 131.98M |
| May 29, 2024 | 131.36M |
| May 28, 2024 | 126.35M |
| May 24, 2024 | 128.86M |
| May 23, 2024 | 129.48M |
| May 22, 2024 | 133.86M |
| May 21, 2024 | 136.36M |
| May 20, 2024 | 142.62M |
| May 17, 2024 | 143.24M |
| May 16, 2024 | 136.99M |
| May 15, 2024 | 138.86M |
| May 14, 2024 | 141.37M |
| May 13, 2024 | 131.98M |
| May 10, 2024 | 130.11M |
| May 09, 2024 | 126.98M |
| May 08, 2024 | 122.60M |
| May 07, 2024 | 105.09M |
| May 06, 2024 | 119.47M |
| May 03, 2024 | 94.15M |
| May 02, 2024 | 84.84M |
| May 01, 2024 | 78.95M |
| April 30, 2024 | 76.01M |
| April 29, 2024 | 77.48M |
| April 26, 2024 | 71.11M |
| Date | Value |
|---|---|
| April 25, 2024 | 72.58M |
| April 24, 2024 | 74.05M |
| April 23, 2024 | 75.03M |
| April 22, 2024 | 70.62M |
| April 19, 2024 | 68.65M |
| April 18, 2024 | 69.14M |
| April 17, 2024 | 66.69M |
| April 16, 2024 | 72.09M |
| April 15, 2024 | 72.09M |
| April 12, 2024 | 75.03M |
| April 11, 2024 | 76.50M |
| April 10, 2024 | 74.05M |
| April 09, 2024 | 79.93M |
| April 08, 2024 | 83.86M |
| April 05, 2024 | 85.82M |
| April 04, 2024 | 82.88M |
| April 03, 2024 | 85.82M |
| April 02, 2024 | 91.21M |
| April 01, 2024 | 91.21M |
| March 28, 2024 | 87.29M |
| March 27, 2024 | 87.78M |
| March 26, 2024 | 86.31M |
| March 25, 2024 | 86.31M |
| March 22, 2024 | 87.78M |
| March 21, 2024 | 90.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
30.18M
Minimum
Mar 28 2023
361.85M
Maximum
Sep 21 2021
95.95M
Average
99.22M
Median
Jun 21 2021
Market Cap Benchmarks
| Cyclacel Pharmaceuticals Inc | 3.834M |
| Enanta Pharmaceuticals Inc | 264.53M |
| Oragenics Inc | 9.051M |
| Nanoviricides Inc | 28.35M |
| MAIA Biotechnology Inc | 103.73M |
Market Cap Related Metrics
| Price to Book Value | 4.050 |
| Price | 2.16 |
| Earnings Yield | -23.61% |